Latest Peer-Reviewed Article

    Theranostics. 2019 Feb 20;9(5):1490-1509. doi: 10.7150/thno.29546.
    Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.
    Goody D, Gupta SK, Engelmann D, Spitschak A, Marquardt S, Mikkat S, Meier C, Hauser C, Gundlach JP, Egberts JH, Martin H, Schumacher T, Trauzold A, Wolkenhauer O, Logotheti S, Pützer BM.

Latest Book-Article

    Methods Mol Biol. 2019;1912:33-52. doi: 10.1007/978-1-4939-8982-9_2.
    p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
    Logotheti S, Marquardt S, Pützer BM.

Latest Abstract

    New Horizons in Translational Medicine Volume 4;1-4:48-98.
    E2F1 signaling promotes chemoresistance and lymphogenic metastasis in penile cancer revealing new prognostic biomarkers.
    Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz J, Naumann CM, Kalthoff H, Herchenröder O, Hakenberg OW, Pützer BM.

Latest Thesis

    Juliane Marie Hartz (Ärztin)
    Analyse metastasierungsrelevanter microRNAs und deren prognostische Bedeutung für das Peniskarzinom

... more Publications

    Cancer Res. 2003; 63:2737-2741.
    p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement.
    Rödicker F, Pützer BM.
    Gene Ther. 2011 Apr;18(4):418-23.
    Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models. Gene Ther. 2011 Apr;18(4):418-23.
    Schmidt A, Eipel C, Fürst K, Sommer N, Pahnke J, Pützer BM.
    J Biol Chem. 2003; 278:14230-14236.
    Inactivation of the RB tumor suppressor gene by oncogenic isoforms of the p53 family member p73.
    Stiewe T, Stanelle J, Theseling CC, Pollmeier B, Beitzinger M, Pützer BM.